Agnico Eagle Mines Ltd vs Tilray Brands Inc — how do they compare? Agnico Eagle Mines Ltd trades at $183.5 (market cap $91.28B), while Tilray Brands Inc trades at $4.77 (market cap $601.34M). The key difference: Agnico Eagle Mines Ltd is far larger — about 151.8× Tilray Brands Inc's market cap, and Agnico Eagle Mines Ltd pays a 1% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| AEM | TLRY | |
|---|---|---|
Market Cap | $91.28B | $601.34M |
Sector | Basic Materials | Health |
52-Week High | $252.19 | $21.00 |
52-Week Low | $130.23 | $3.88 |
Enterprise Value | $88.12B | $768.47M |
Dividend Yield | 1% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.
Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.
Trailing returns across standard periods
Latest headlines on both assets
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →